IP Verse

Neutralization Of Inhibitory Pathways In Lymphocytes

Patent No. EP3799885 (titled "Neutralization Of Inhibitory Pathways In Lymphocytes") was filed by Innate Pharma on Sep 15, 2015. The application was issued on Aug 13, 2025.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
STRAWMANMay 13, 2026ZWICKER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP3799885

INNATE PHARMA
Application Number
EP20181825A
Filing Date
Sep 15, 2015
Status
Granted And Under Opposition
Jul 11, 2025
Publication Date
Aug 13, 2025
External Links
Slate, Register , Google Patents